[go: up one dir, main page]

ATE373466T1 - Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung - Google Patents

Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung

Info

Publication number
ATE373466T1
ATE373466T1 AT02774211T AT02774211T ATE373466T1 AT E373466 T1 ATE373466 T1 AT E373466T1 AT 02774211 T AT02774211 T AT 02774211T AT 02774211 T AT02774211 T AT 02774211T AT E373466 T1 ATE373466 T1 AT E373466T1
Authority
AT
Austria
Prior art keywords
methods
lipid carrier
carrier compositions
improved active
active retention
Prior art date
Application number
AT02774211T
Other languages
English (en)
Inventor
Murray Webb
Paul Tardi
Original Assignee
Celator Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celator Pharmaceuticals Inc filed Critical Celator Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE373466T1 publication Critical patent/ATE373466T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02774211T 2001-11-13 2002-11-13 Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung ATE373466T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33124901P 2001-11-13 2001-11-13

Publications (1)

Publication Number Publication Date
ATE373466T1 true ATE373466T1 (de) 2007-10-15

Family

ID=23293193

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02774211T ATE373466T1 (de) 2001-11-13 2002-11-13 Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung

Country Status (7)

Country Link
US (1) US20050118249A1 (de)
EP (1) EP1448165B1 (de)
AT (1) ATE373466T1 (de)
AU (1) AU2002340670A1 (de)
DE (1) DE60222580T2 (de)
ES (1) ES2290333T3 (de)
WO (1) WO2003041682A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4874548B2 (ja) * 2002-11-26 2012-02-15 ギリアード サイエンシーズ， インコーポレイテッド 勾配によるリポソームへの薬物充填方法
JP2007522085A (ja) * 2003-06-27 2007-08-09 スミスクライン・ビーチャム・コーポレイション 安定化されたトポテカンリポソーム組成物および方法
EP1757270A1 (de) * 2004-04-02 2007-02-28 Italfarmaco, S.A. Liposomale formulierungen
CA2567857C (en) 2004-06-01 2009-12-22 Terumo Kabushiki Kaisha Irinotecan liposome formulation
US20090148506A1 (en) * 2005-12-22 2009-06-11 Awa Dicko Liposomal formulations comprising secondary and tertiary amines and methods for preparing thereof
WO2009059449A1 (en) * 2007-11-05 2009-05-14 Celsion Corporation Novel thermosensitive liposomes containing therapeutic agents
EP2123258A1 (de) * 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomen zur Arzneimittelverabreichung
SI2415470T1 (sl) 2009-03-30 2016-12-30 Eisai R&D Management Co., Ltd. Liposomski sestavek
US9968583B2 (en) * 2009-03-30 2018-05-15 Eisai R & D Management Co., Ltd. Method of manufacture of liposome composition
DK177532B1 (en) * 2009-09-17 2013-09-08 Bio Bedst Aps Medical use of sPLA2 hydrolysable liposomes
EP2651447B1 (de) 2010-12-14 2018-08-29 Technical University of Denmark Einschluss von radionukliden in nanoteilchenzusammensetzungen
PT2768484T (pt) 2011-10-21 2019-10-28 Jazz Pharmaceuticals Res Llc Lipossomas liofilizados
WO2014047116A1 (en) * 2012-09-18 2014-03-27 Comfort Care For Animals Llc Encapsulating liposomes
US10039716B2 (en) 2013-03-13 2018-08-07 Mallinckrodt Llc Liposomal cisplatin compositions for cancer therapy
US9993427B2 (en) * 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
MX381655B (es) * 2015-05-04 2025-03-13 Versantis AG Metodo para preparar vesiculas con gradiente de ph de transmembrana.
EP3449921B1 (de) 2016-04-28 2023-05-31 Eisai R&D Management Co., Ltd. Eribulin zur hemmung des tumorwachstums
US12036204B2 (en) 2019-07-26 2024-07-16 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US859494A (en) * 1905-10-17 1907-07-09 Walter C Hardesty Trousers-press.
US2202857A (en) * 1939-07-26 1940-06-04 Henney Motor Co Footrest for vehicles
US5736155A (en) * 1984-08-08 1998-04-07 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US5622713A (en) * 1985-09-17 1997-04-22 The Regents Of The University Of California Method of detoxifying animal suffering from overdose
ATE68968T1 (de) * 1985-11-22 1991-11-15 Takeda Chemical Industries Ltd Liposomzusammensetzung.
JPH0617309B2 (ja) * 1985-11-29 1994-03-09 株式会社ビタミン研究所 アドリアマイシン包埋リポソ−ム製剤
IL81264A (en) * 1986-01-30 1990-11-05 Takeda Chemical Industries Ltd Quinone derivatives,their production and pharmaceutical compositions containing them
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
DE3718581C1 (de) * 1987-06-03 1988-12-29 Helmut Steinhilber Vorrichtung zum Schonen der Schuhe des Fahrers eines Kraftfahrzeugs
US4915951A (en) * 1987-12-03 1990-04-10 California Institute Of Technology Cryoprotective reagent
DE69014885T2 (de) * 1989-06-22 1995-04-27 Vestar Inc Einkapselverfahren.
WO1991004019A1 (en) * 1989-09-12 1991-04-04 The Regents Of The University Of California Therapeutic peptides and proteins
US5225212A (en) * 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
IS1685B (is) * 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
US5683714A (en) * 1991-04-19 1997-11-04 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin pharmaceutical formulation
PT101422B (pt) * 1993-12-06 1997-06-30 Ineti Inst Biotec Q F E Tecnol Formulacoes lipossomicas contendo vidarabina e/ou derivados, com indice terapeutico elevado e processo para a sua preparacao
US5993850A (en) * 1994-09-13 1999-11-30 Skyepharma Inc. Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
CN1165480A (zh) * 1994-10-03 1997-11-19 M·G·伯杰龙 治疗病毒性疾病的脂质体组合物
US6331289B1 (en) * 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors
US5827532A (en) * 1997-01-31 1998-10-27 The Reagents Of The University Of California Method for loading lipsomes with ionizable phosphorylated hydrophobic compounds, pharmaceutical preparations and a method for administering the preparations
US5827533A (en) * 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
US5962015A (en) * 1997-05-02 1999-10-05 Kobo Products S.A.R.L. Stabilized liposomes
US6106858A (en) * 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
US6306432B1 (en) * 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
US5967602A (en) * 1998-01-08 1999-10-19 Hoover Universal, Inc. Extending cargo shelf for vehicle seat
US6200598B1 (en) * 1998-06-18 2001-03-13 Duke University Temperature-sensitive liposomal formulation
US6270806B1 (en) * 1999-03-03 2001-08-07 Elan Pharma International Limited Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
US6145931A (en) * 1999-03-18 2000-11-14 Subotic; Slobodan Article for use in putting on and removing shoes
NZ516648A (en) * 1999-07-16 2004-01-30 Alza Corp A liposome composition having resistance to freeze/thaw damage
US6390547B1 (en) * 2000-01-07 2002-05-21 Johnson Controls Technology Company Seat assembly

Also Published As

Publication number Publication date
DE60222580T2 (de) 2008-06-12
US20050118249A1 (en) 2005-06-02
EP1448165A2 (de) 2004-08-25
AU2002340670A1 (en) 2003-05-26
WO2003041682A3 (en) 2003-09-18
DE60222580D1 (de) 2007-10-31
EP1448165B1 (de) 2007-09-19
WO2003041682A2 (en) 2003-05-22
ES2290333T3 (es) 2008-02-16

Similar Documents

Publication Publication Date Title
ATE373466T1 (de) Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
IL140710A0 (en) Pulmonary delivery of active agents
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
DK0478686T3 (da) Flour- og phosphorholdige amphiphile molekyler med overfladeaktive egenskaber
DE60104206D1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
EA199700197A1 (ru) Стабильные белково-фосфолипидные составы и способы их получения
BRPI0415409A (pt) uso de efetuadores de ciclases de glutaminila e glutamato
DE69931930D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
DK0783297T3 (da) Polyethylenglycol-modificerede ceramid-lipider og liposomer
RU95112465A (ru) Пирановые соединения, фармацевтическая композиция, способ получения и промежуточные соединения
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
BR0113477A (pt) Peptìdios de penetração em membranas e usos dos mesmos
ATE453380T1 (de) Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen
WO2003099830A3 (en) Cardiolipin compositions, methods of preparation and use
SE9801536L (sv) Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
SE0003476D0 (sv) Compounds
WO2000033887A3 (en) Methods and formulations for reducing circulating antibodies
DE59108850D1 (de) Wirkstofffreie Liposomen zur Behandlung von Atherosklerose
PL342624A1 (en) Derivatives of streptogramines, method of obtaining them and compositions containing such derivatives
AP2000001937A0 (en) Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway.
DE59907526D1 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-cyclohexanon
ATE345778T1 (de) (ester)-lysolecithine in liposomen
WO2001085131A3 (en) Lipid carrier compositions for improved drug retention

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties